Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, and RNA modifications and cancer.
The X-Age Project to construct a Chinese aging clock
DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement
A framework of biomarkers for vascular aging: a consensus statement by the Aging Biomarker Consortium
A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement
Effects of <scp>HMGB1</scp>/<scp>RAGE</scp>/cathespin B inhibitors on alleviating hippocampal injury by regulating microglial pyroptosis and caspase activation in neonatal hypoxic–ischemic brain damage
Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation
TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker
Type 2 diabetes is more closely associated with risk of colorectal cancer based on elevated DNA methylation levels of ADCY5
Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma
miR-30c plays diagnostic and prognostic roles and mediates epithelial–mesenchymal transition (EMT) and proliferation of gliomas by affecting Notch1
Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non‑small cell lung cancer
The lncRNA ALMS1‐IT1 may promote malignant progression of lung adenocarcinoma via AVL9‐mediated activation of the cyclin‐dependent kinase pathway
LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling
Polypeptide Globular Adiponectin Ameliorates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Necroptosis
Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation
The role of long non‐coding <scp>RNAs</scp> in drug resistance of cancer
Comparison of the Characteristics and Risk Factors of Carotid Atherosclerosis in High Stroke Risk Populations Between Urban and Rural Areas in North China
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
LncRNA LOXL1‐AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR‐708‐5p/USF1 pathway
Long noncoding RNA VCAN‐AS1 contributes to the progression of gastric cancer via regulating p53 expression
miR‐155‐5p and miR‐760 mediate radiation therapy suppressed malignancy of non‐small cell lung cancer cells
RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer
miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling
MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6
Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction
The role of miR-130a in cancer
DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice
MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer